Invesaro

Stocks IONQ Financial statements

Financial statements

IonQ, Inc. financial statements

Income statement, balance sheet and cash flow statement for the last 6 fiscal years, taken from the XBRL data IonQ, Inc. files with the SEC in its annual reports.

In USD millions, except per-share amounts. Outflows in the cash flow statement are negative.

Income statement

FY2020FY2021FY2022FY2023FY2024FY2025
Revenue02.11,2352243.1130
Cost of revenue0.141.042.948.1120.677.5
Gross profit-0.141.061,23213.922.552.5
Research and development10.220.24492.3137306
Selling and marketing0.493.238.3918.328.453.4
General and administrative3.5513.73650.771.1245
Operating income-15.7-38.7-85.7-158-232-634
Other non-operating income0.030.01-0.09-0.280.03
Pre-tax income-15.4-106-48.5-158-332-557
Income tax0000.050.06-44.6
Net income to minority interests00-1.74
Net income-15.4-106-48.5-158-332-510
EBITDA-14.3-36.1-80.1-147-214-552
EPS, basic-0.13-0.77-0.25-0.78-1.56-1.82
EPS, diluted-0.13-0.77-0.25-0.78-1.56-1.82
Shares, basic (weighted)115138198203213280
Shares, diluted (weighted)115138198203213280

Balance sheet

FY2020FY2021FY2022FY2023FY2024FY2025
Cash and equivalents36.139944.435.754.41,031
Short-term investments01233113202861,361
Receivables0.390.713.2911.510.266.5
Inventory010.3
Other current assets2.076.443.422.82.5625.1
Total current assets38.65303723903792,586
Property, plant and equipment1218.92637.552.8120
Lease right-of-use assets4.34.033.754.619.4722.7
Goodwill00.740.749.91,964
Intangible assets2.695.848.9415.129.5767
Long-term investments080.118210023.5945
Other non-current assets2.933.564.915.164.44165
Total assets60.56425985545086,570
Accounts payable0.541.883.065.65.2326.1
Accrued liabilities0.612.656.6618.416.889.7
Deferred revenue0.243.438.7312.110.742.1
Total current liabilities1.889.6920.237.236.1167
Lease liabilities3.783.643.467.414.421.2
Other non-current liabilities00.30.133.3995.2
Total liabilities6.7850.829.868.61252,757
Paid-in capital93.37377708391,0675,006
Retained earnings-39.6-146-194-352-684-1,194
Other comprehensive income0-0.15-7.36-1.970.16-12.7
Shareholders' equity53.75915684853843,800
Minority interests014.2
Total equity53.75915684853843,814
Total liabilities and equity60.56425985545086,570
Shares outstanding118196200207222363

Cash flow statement

FY2020FY2021FY2022FY2023FY2024FY2025
Net income-15.4-106-48.5-158-332-512
Depreciation and amortization1.42.555.610.418.782
Stock-based compensation1.227.7531.569.7107312
Deferred income tax000-44.9
Change in receivables-0.29-0.32-1.51-8.181.61-37.7
Change in payables0.10.761.062.19-0.6-7.64
Cash from operations-12-26.5-44.7-78.8-106-283
Capital expenditures-10-7.78-9.34-13.7-18-16.4
Acquisitions0-0.850-15.50.52
Purchases of investments-204-606-298-296-2,669
Sales and maturities of investments0310387418683
Cash from investing-11.7-214-30968.882.7-2,095
Stock issued0.285.461.06003,313
Cash from financing0.286031.11.7641.73,359
Exchange rate effect0-00.030.58
Net change in cash-23.4363-353-8.2918.8981
Free cash flow-22-34.3-54-92.5-124-300
Income taxes paid000

Key metrics

Worked out from the statements above. Latest values use the trailing twelve months to June 30, 2026; growth uses fiscal years. Valuation uses the share price of $45.48 on September 25, 2026.

Profitability

MetricValueHow it is calculated
Gross margin29.3%Gross profit / revenue.
Operating margin-408.2%Operating income / revenue.
EBITDA margin-345.7%EBITDA (operating income + depreciation and amortization) / revenue.
Pre-tax margin-571.3%Pre-tax income / revenue.
Net margin-553.3%Net income / revenue.
FCF margin-196.3%Free cash flow (cash from operations - capital expenditures) / revenue.
Operating cash flow margin-183.5%Cash from operations / revenue.
Return on equity (ROE)-41.0%Net income / average shareholders' equity (opening and closing). Not shown when equity is negative.
Return on assets (ROA)-20.1%Net income / average total assets.
Return on invested capital (ROIC)-38.0%Approximation: operating income x (1 - tax rate) / average (total debt + equity - cash). Tax rate is the effective rate when between 0% and 50%, else 21%.
R&D / revenue182.1%Research and development expense / revenue.
Stock-based pay / revenue184.4%Stock-based compensation (from the cash flow statement) / revenue.
Capex / revenue12.8%Capital expenditures / revenue.
D&A / revenue62.5%Depreciation and amortization / revenue.

Growth

MetricValueHow it is calculated
Revenue growth, 1y201.9%Revenue vs the same period a year earlier. Only from a positive base.
Revenue CAGR, 3y-52.8%Compound annual growth of revenue over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Gross profit growth, 1y133.7%Gross profit vs the same period a year earlier. Only from a positive base.
Gross profit CAGR, 3y-65.1%Compound annual growth of gross profit over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Book value growth, 1y889.8%Book value vs the same period a year earlier. Only from a positive base.
Book value CAGR, 3y88.4%Compound annual growth of book value over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Book value CAGR, 5y134.4%Compound annual growth of book value over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Total assets growth, 1y1,192.0%Total assets vs the same period a year earlier. Only from a positive base.
Total assets CAGR, 3y122.3%Compound annual growth of total assets over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Total assets CAGR, 5y155.4%Compound annual growth of total assets over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Share count change, 1y31.6%Change in diluted weighted shares vs a year earlier. Negative means buybacks shrank the share count; positive means dilution.
Share count change per year, 3y12.3%Change in diluted weighted shares, per year over 3 years. Negative means buybacks shrank the share count; positive means dilution.
Share count change per year, 5y19.5%Change in diluted weighted shares, per year over 5 years. Negative means buybacks shrank the share count; positive means dilution.

Balance sheet health

MetricValueHow it is calculated
Current ratio10.7xCurrent assets / current liabilities.
Quick ratio9.84x(Cash + short-term investments + receivables) / current liabilities.
Cash ratio9.37x(Cash + short-term investments) / current liabilities.
Liabilities / assets50.7%Total liabilities / total assets.
Working capital$2.18BCurrent assets - current liabilities.
Goodwill and intangibles / assets43.7%(Goodwill + intangible assets) / total assets.
Tangible book value$362.4MShareholders' equity - goodwill - intangible assets.

Efficiency

MetricValueHow it is calculated
Asset turnover0.04xRevenue / average total assets.
Fixed asset turnover1.71xRevenue / average property, plant and equipment.
Inventory turnover6.98xCost of revenue / average inventory.
Days inventory52 days365 x average inventory / cost of revenue.
Receivables turnover2.33xRevenue / average receivables.
Days sales outstanding157 days365 x average receivables / revenue.
Days payables93 days365 x average accounts payable / cost of revenue.
Cash conversion cycle116 daysDays inventory + days sales outstanding - days payables.

Per share

MetricValueHow it is calculated
EPS, diluted-$3.71Net income per diluted share, as reported (split-adjusted). Over the last twelve months: the four quarters summed, or net income / latest diluted shares when a quarter has no reported EPS.
Revenue per share$0.67Revenue / diluted weighted shares.
FCF per share-$1.32Free cash flow / diluted weighted shares.
Operating cash flow per share-$1.23Cash from operations / diluted weighted shares.
Book value per share$8.73Shareholders' equity / shares outstanding (diluted weighted shares when not reported).
Tangible book per share$0.95Tangible book value / shares outstanding.
Cash per share$5.56(Cash + short-term investments) / shares outstanding.

Valuation

MetricValueHow it is calculated
Market cap$17.33BShare price x shares outstanding.
Enterprise value$15.21BMarket cap + total debt - cash - short-term investments.
P/S70.3xMarket cap / revenue.
P/B5.21xMarket cap / shareholders' equity. Only when equity is positive.
Price / tangible book47.8xMarket cap / tangible book value, when positive.
EV/Sales61.7xEnterprise value / revenue.
FCF yield-2.8%Free cash flow / market cap.
Earnings yield-7.9%Net income / market cap (the inverse of P/E).
What was IonQ, Inc.'s revenue in fiscal 2025?

IonQ, Inc. reported revenue of $130.0M for fiscal 2025, 201.9% higher than the year before.

Was IonQ, Inc. profitable in fiscal 2025?

No. It reported a net loss of $510.4M.

How much free cash flow did IonQ, Inc. generate in fiscal 2025?

Cash from operations of $283.2M minus capital expenditures of $16.4M left free cash flow of -$299.6M.

Source: SEC EDGAR XBRL company facts. Where a company tags only year-to-date figures, quarters are worked out as differences. Where a line is not tagged it is left empty, never estimated.

Open interactive statements, quarterly figures and charts

Back to IonQ, Inc.